Pandemics and Alertness member WG1 (Understanding the virus) and WG3 (Complementary and enabling techniques), LINXS Fellow

European Spallation Source ERIC, Lund, Sweden

Dr. Suzanne Zoë Fisher completed her Bachelor of Science (B.Sc.) and Honours (Hons.) degree in Biochemistry and Animal Physiology at the University of Stellenbosch in 1999 and 2000, respectively. In December 2000, she emigrated to the United States, where she worked as a research assistant in the Department of Physiology and Cell Biology at the University of Florida for nearly two years before beginning her graduate studies in 2002. She earned her Ph.D. in structural biology from the Department of Biochemistry and Molecular Biology, UF in 2006. She then joined Los Alamos National Laboratory (LANL) in Los Alamos, New Mexico, as a postdoctoral research associate from 2007 to 2010. Following her postdoctoral work, she became a permanent staff member at LANL, serving as a Research Scientist II from 2010 to 2014. In this role, she was responsible for the Protein Crystallography Station and its affiliated deuteration and crystallization support laboratory

In 2014, Dr. Fisher moved to Sweden to join the European Spallation Source (ESS) in Lund. She currently serves as a Senior Scientist at the ESS and holds an adjunct Senior Lecturer position in the Department of Biology at Lund University. Dr. Fisher has extensive expertise in structural biology, protein biochemistry, neutron and X-ray crystallography, and stable isotope labeling for NMR and neutron applications. She is an active member of the scientific community, having served as a LINXS fellow, a Scientific Advisory Board member for Prosel Biosciences, and a board member of the DeuNet network. She is also engaged in education and outreach, has participated in numerous schools, workshops, conferences, and regularly delivers talks or seminars to diverse audiences to promote the applications of neutrons in structural biology. Dr. Fisher has authored or co-authored more than 80 peer-reviewed publications, including recent studies on SARS-CoV-2 nonstructural proteins nsp10 and nsp14.